Ledge Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,294
Closed -$257K 69
2023
Q1
$257K Sell
6,294
-438
-7% -$18.9K 0.12% 58
2022
Q4
$345K Hold
6,732
0.16% 60
2022
Q3
$295K Sell
6,732
-740
-10% -$36K 0.18% 57
2022
Q2
$392K Hold
7,472
0.24% 54
2022
Q1
$387K Buy
+7,472
New +$388K 0.24% 60

Other funds holding PFE

Ledge Wealth Management's PFE Position: Q2 2023 in Review

Ledge Wealth Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 6,294 shares — an estimated $257K sold.

Ledge Wealth Management first reported a position in PFE in Q1 2022 and held it in 5 quarters. The position peaked at $392K in Q2 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Ledge Wealth Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Ledge Wealth Management sold 6,294 Pfizer shares in Q2 2023, an estimated $257K.
  • Ledge Wealth Management first reported a position in Pfizer in Q1 2022 and held it in 5 quarters.
  • Ledge Wealth Management's Pfizer position peaked at $392K in Q2 2022.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Ledge Wealth Management's 13F filing for Q2 2023, filed 12 Jul 2023.